TITAN Shoulder
Device
Smith+Nephew, Inc.
Total Payments
$91,431
Transactions
191
Doctors
103
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $91,431 | 191 | 103 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,316 | 38 | 66.0% |
| Consulting Fee | $16,746 | 10 | 18.3% |
| Food and Beverage | $8,055 | 130 | 8.8% |
| Travel and Lodging | $4,301 | 12 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,013 | 1 | 2.2% |
Payments by Type
Research
$60,316
38 transactions
General
$31,114
153 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prospective, Multicenter; A Post-Market Clinical Follow-up Study of the TITAN Reverse Shoulder System used in Primary or Revision Total Shoulder Arthroplasty | Smith+Nephew, Inc. | $33,122 | 1 |
| A Post Market, Prospective, Non-Randomized, Multi-Center, Open-Label Clinical Evaluation of the Integra Cadence Total Ankle System in Primary Ankle Joint Replacement | Smith+Nephew, Inc. | $16,228 | 0 |
| A Post Market, Prospective Non-Randomized, Multi-Center, Open Label Clinical Evaluation of the Integra TITAN Modular Shoulder System2.5 Primary Shoulder Joint Replacement | Smith+Nephew, Inc. | $10,967 | 0 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $91,431
Product Information
- Type Device
- Total Payments $91,431
- Total Doctors 103
- Transactions 191
About TITAN Shoulder
TITAN Shoulder is a device associated with $91,431 in payments to 103 healthcare providers, recorded across 191 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2021 to 2021. In 2021, $91,431 was paid across 191 transactions to 103 doctors.
The most common payment nature for TITAN Shoulder is "Unspecified" ($60,316, 66.0% of total).
TITAN Shoulder is associated with 3 research studies, including "Prospective, Multicenter; A Post-Market Clinical Follow-up Study of the TITAN Reverse Shoulder System used in Primary or Revision Total Shoulder Arthroplasty" ($33,122).